Medical Breakthrough: InThrill Thrombectomy System Unveiled by Stryker’s Inari Medical

Recently, Inari Medical, now part of Stryker (NYSE: SYK), announced the launch of its next-generation InThrill thrombectomy system.

The issue of thrombosis has always been a challenging problem plaguing the medical community. It is like a "time bomb" hidden in the human blood vessels, which may trigger a serious health crisis at any time, from deep vein thrombosis to pulmonary embolism. These conditions not only cause great suffering to patients but may even be life-threatening. The emergence of InThrill Thrombectomy System undoubtedly brings new hope for solving these problems. Everyone is full of expectations and curiosity about its unique features and the potential revolution it may bring to thrombus treatment.

The birth of the InThrill thrombectomy system is inseparable from the powerful collaboration between Stryker and Inari Medical. On January 6, 2025, Stryker announced the acquisition of Inari Medical for $80 per share in cash, with a total transaction value of approximately $4.9 billion, equivalent to about 36 billion yuan. This announcement immediately caused a stir within the industry, becoming the focal point of discussion in the medical field at that time.

Stryker, this medical giant established in 1941, is headquartered in the United States and holds a pivotal position in the global medical device industry. It is a leading global manufacturer of orthopedic and medical devices, ranking as the fifth-largest medical device company worldwide. Its business spans a wide range of fields, including orthopedics, neurovascular, sports medicine, and more. With deep technical expertise and outstanding innovation capabilities, it enjoys extremely high recognition and reputation in the market.

Inari Medical, founded in 2011, is relatively young but has achieved remarkable success in the field of venous thromboembolism (VTE) treatment. It is a leading enterprise in peripheral interventions and ranked 88th in the 2024 Global Top 100 Medical Device Companies. Its FlowTriever system is the first mechanical thrombectomy system approved by the U.S. FDA for treating pulmonary embolism, while the ClotTriever system has shown excellent performance in deep vein thrombosis treatment. These products have brought hope to many patients and enabled Inari Medical to make a name for itself in the medical market.

Stryker’s Acquisition of Inari Medical: A Win-Win Strategic Decision

For Inari Medical, joining the Stryker family means gaining stronger financial support, broader resources, and enhanced R&D and production capabilities. This will accelerate its pace of technological innovation and product promotion, allowing more patients to benefit from its advanced medical technology. It can be said that this acquisition has laid a solid foundation for the development and launch of the InThrill thrombectomy system, and it also fills us with anticipation for the future collaboration between the two companies in the medical field.

(1) Unique Design, Directly Addressing Pain Points

InThrill Thrombectomy System Features an Ingenious Design with Enhanced Radial Force for Better Luminal Wall Apposition. This ensures tighter contact between the thrombectomy catheter and the vessel wall, optimizing clot removal. As a result, even those challenging clots stand no chance against InThrill's powerful "assault."

The design of its offset single opening is also absolutely ingenious. Imagine using a spoon with an offset mouth to scoop beans from a bowl; the offset mouth allows for more precise targeting of the beans, making it easy to scoop them up. The offset single opening functions like this offset-mouthed spoon, optimizing the capture and removal of clots. It can more effectively "grab" thrombi and smoothly remove them from blood vessels. Meanwhile, the internal strut design acts like the beams of a house, providing stable support for the entire system, ensuring even distribution of clots within the component, preventing clot accumulation and blockages, further enhancing the efficiency of thrombus removal.

(II) Optimize Experience, Operation Upgrade

InThrill Thrombectomy System Has Fully Considered This Point and Redesigned the Backend, Greatly Simplifying Ergonomics. The New Backend Design Is More in Line with the Operating Habits of Doctors, Allowing Them to Operate the Equipment More Easily and Conveniently During Surgery. Just Like Using a New Mobile Phone, If Its Button Layout Is Reasonable and the Operation Interface Is Simple and Easy to Understand, We Can Quickly Get Started and Use It Very Smoothly. The Backend Design Improvement of the InThrill Thrombectomy System Brings Such Convenience to Doctors, Enabling Them to Focus More on the Surgery Itself and Improve the Success Rate of the Surgery.

This optimization not only improves the operational efficiency of doctors but also reduces the risks associated with improper handling. In a high-pressure surgical environment, every detail can impact the outcome of the surgery. The user-centered design philosophy of the InThrill thrombectomy system allows doctors to handle various complex surgical scenarios with greater confidence, safeguarding the health of patients.

(III) Innovative Materials, Efficient Thrombectomy

The innovation of the InThrill thrombectomy system is also reflected in the use of materials. It employs a newly designed nitinol component with unique shape memory characteristics and superelasticity. In the medical field, it functions like a "Transformer," capable of altering its shape as needed to adapt to different vascular environments. The nitinol component in the InThrill thrombectomy system can achieve wall-to-wall clot removal in vessels ranging from 4 to 10 millimeters. Whether in small vessels or irregularly shaped ones, it handles them all with ease.

Compared with traditional thrombectomy materials, nickel-titanium components possess better flexibility and elasticity, allowing for more effective removal of blood clots without damaging the blood vessel walls. It acts like a gentle "scavenger," clearing thrombi from vessels without causing additional harm. The innovative application of this material represents a new breakthrough in thrombus treatment, enabling patients to experience less pain and recover more quickly during treatment.

Dr. Joshua Pinter and Dr. Anish Ghodadra of the UPMC healthcare system performed the first commercial cases using InThrill in May. Dr. Pinter enthusiastically stated that the latest generation of the InThrill thrombectomy system makes thrombectomy "more effective and consistent than ever before." This simple statement carries significant implications. In the past, thrombectomy often faced numerous challenges, such as incomplete clot removal and inconsistent surgical outcomes, which have long troubled doctors and patients. The advent of the InThrill thrombectomy system is like a sharp sword cutting through these difficulties. With its highly efficient clot-removal capability, it makes surgeries smoother and gives patients hope for recovery.

Dr. Ghodadra also added that this small-vessel tool "has changed the paradigm of how we treat thrombectomy in atrioventricular access." A paradigm shift signifies a complete innovation in treatment concepts and methods. The InThrill Thrombectomy System, with its unique design and advanced technology, has brought entirely new approaches to thrombectomy in atrioventricular access. It provides doctors with a more powerful tool when facing these complex procedures, enabling them to deliver more precise and effective treatment for patients.

Apart from the high praise from doctors, the performance of the InThrill thrombectomy system in real cases is also evident. In some clinical cases, patients experienced rapid improvement after being treated with the InThrill thrombectomy system. The blood vessels that were originally blocked by thrombi regained patency under the effect of InThrill, allowing normal blood flow to resume. The patients' symptoms were significantly alleviated, and their quality of life was greatly improved. These real cases are like vivid stories, narrating the miraculous effects of the InThrill thrombectomy system and instilling more confidence in it among people.

The launch of InThrill Thrombectomy System is undoubtedly a feast in the medical field. It is like a brilliant star, illuminating the path of thrombus treatment and bringing new hope to countless patients. Its unique design, advanced technology, and outstanding clinical outcomes allow us to witness the limitless potential of medical technology.

Looking to the future, with the continuous advancement of technology, we have reason to believe that the field of thrombosis treatment will see more breakthroughs. Perhaps in the near future, thrombotic diseases will no longer be a health challenge for humanity, and doctors will be able to address various thrombosis issues more easily and effectively, freeing patients from the suffering caused by these conditions.

The road of medical innovation is endless, and every new technology and breakthrough embodies the hard work and wisdom of researchers and healthcare workers. Let us pay attention to medical innovation together and look forward to more "magic tools" like the InThrill thrombectomy system, contributing to the cause of human health. If you have any thoughts or questions about the InThrill thrombectomy system or the field of medical innovation, feel free to leave a comment and share. Let’s discuss the future of medicine together.

This Issue's Planning: Shen Li

Editor-in-Chief: Chen Baolin

Author of this article: Yun Ye Xuan

Post-production: Zhang Lirong